🔗 Permalink

Inventor profile of:

Thomas Malcolm

City:

Andover, New Jersey

Country:

United States

Published Applications:

21

Last publication date:

2025-12-25

Top Assignees for applications by Thomas Malcolm

The entities that hold a legal rights for patent applications filed by inventor Malcolm Thomas:

EXCISION BIOTHERAPEUTICS, INC. 4 Andover, NJ United States
Temple University of the Commonwealth System of Higher Education 3 Philadelphia, PA United States
EXCISION BIOTHERAPEUTICS,INC. 1 Andover, NJ United States
Thomas Malcolm 1 Andover, NJ United States
Excision BioTherapeutics, Inc. 1 Bedminster, NJ United States
Excision Bio Therapeutics, Inc. 1 Andover, NJ United States

Recent patent applications by Malcolm Thomas

Thomas Malcolm from Andover, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-12-25

US20250387515A1

Human necessities

HYPOIMMUNOGENIC BIOMIMETIC NANOVESICLE GENE EDITING SYSTEM FOR HIV INFECTION

#2 | 2025-10-30

US20250332115A1

Human necessities

CONTROLLED EXPRESSION OF THERAPEUTICALLY RELEVANT BIOMOLECULES FOR LUMEN-LOCALIZED PAYLOADS IN BIOMIMETIC NANOVESICLES AND EXOSOMES

#3 | 2025-07-31

US20250242046A1

Human necessities

ALLOGENEIC HYPOIMMUNE BIOMIMETIC NANOVESICLE FOR THE TREATMENT OF CANCER

#4 | 2024-09-19

US20240307317A1

Human necessities

TAILORED HYPOIMMUNENANOVESICULAR DELIVERY SYSTEMS FOR CANCER TUMORE, HEREDITARY AND INFECTIOUS DISEASES

#5 | 2024-02-15

US20240050547A1

Human necessities

METHODS OF BLOCKING / NEUTRALIZING ASFV INFECTION THROUGH INTERRUPTION OF CELLULAR AND VIRAL RECEPTOR INTERACTIONS

#6 | 2023-07-27

US20230233654A1

Human necessities

GENE EDITING METHODS AND COMPOSITIONS FOR ELIMINATING RISK OF JC VIRUS ACTIVATION AND PML (PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY) DURING IMMUNOSUPPRESSIVE THERAPY

#7 | 2023-05-11

US20230144704A1

Human necessities

TAILORED HYPOIMMUNE NANOVESICULAR DELIVERY SYSTEMS FOR CANCER TUMORS, HEREDITARY AND INFECTIOUS DISEASES

#8 | 2023-02-16

US20230048681A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS OF TREATMENT FOR LYTIC AND LYSOGENIC VIRUSES

#9 | 2022-09-15

US20220290177A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR EXCISION WITH SINGLE GRNA

#10 | 2022-08-04

US20220241391A1

Human necessities

METHODS OF BLOCKING ASFV INFECTION THROUGH INTERRUPTION OF CELLULAR AND VIRAL RECEPTOR INTERACTIONS

#11 | 2022-07-14

US20220218842A1

Human necessities

TAILORED HYPOIMMUNE NANOVESICULAR DELIVERY SYSTEMS FOR CANCER TUMORS

#12 | 2022-02-10

US20220040106A1

Human necessities

TAILORED HYPOIMMUNE NANOVESICULAR DELIVERY SYSTEMS FOR CANCER TUMORS, HEREDITARY AND INFECTIOUS DISEASES

#13 | 2020-03-26

US20200095586A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS OF TREATMENT FOR LYTIC AND LYSOGENIC VIRUSES

#14 | 2019-11-07

US20190338315A1

Chemistry; metallurgy

CLOAKED CRISPRs

#15 | 2019-11-07

US20190336617A1

Human necessities

CRISPRs IN SERIES TREATMENT

#16 | 2019-09-19

US20190285632A1

METABALOMICS AND VIRAL DIAGNOSTICS SUITE

#17 | 2019-08-15

US20190247470A1

Human necessities

Gene editing methods and compositions for eliminating risk of JC virus activation and PML (progressive multifocal leukoencephalopathy) during immunosuppressive therapy

#18 | 2019-06-27

US20190194652A1

Chemistry; metallurgy

HIV CLINICAL PLAN

#19 | 2019-03-07

US20190071673A1

Chemistry; metallurgy

CRISPRs WITH IMPROVED SPECIFICITY

#20 | 2019-02-07

US20190038770A1

Human necessities

RNA GUIDED ERADICATION OF HUMAN JC VIRUS AND OTHER POLYOMAVIRUSES

#21 | 2019-01-31

US20190032057A1

Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION

InventorID:

2415162 ⎘